Owings Mills, Maryland Clinical Trials

A listing of Owings Mills, Maryland clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 75 clinical trials
A 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine

The reason for this 12-month, open-label study is to see if the study drug lasmiditan is safe and effective for the intermittent acute treatment of migraine in children aged 6 to 17. The study will last about 12 months and may include up to 7 visits.

migraine in children
acute treatment
lasmiditan
ly573144
PharmaSite Research Inc
 (4.0 away) Contact site
  • 129 views
  • 25 Nov, 2020
  • +211 other locations
A Study of Seltorexant Compared to Quetiapine XR as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant Therapy

The purpose of this study is to assess the efficacy of seltorexant compared with quetiapine extended-release (XR) as adjunctive therapy to an antidepressant drug in treatment response in participants with major depressive disorder with insomnia symptoms (MDDIS) who have had an inadequate response to current antidepressant therapy with a selective …

hdrs
depressive symptoms
vilazodone
citalopram
psychosis
Pharmasite Research, Inc.
 (4.0 away) Contact site
  • 124 views
  • 23 Nov, 2020
  • +165 other locations
Testing MK-3475 (Pembrolizumab) After Surgery for Localized Muscle-Invasive Bladder Cancer and Locally Advanced Urothelial Cancer

This randomized phase III trial studies how well pembrolizumab works in treating patients with bladder cancer that has spread into the deep muscle of the bladder wall (muscle-invasive) or urothelial cancer that has spread from where it started to nearby tissue or lymph nodes (locally advanced). Monoclonal antibodies recognizing and …

UM Saint Joseph Medical Center
 (7.6 away) Contact site
  • 836 views
  • 25 Nov, 2020
  • +724 other locations
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer ALCHEMIST Chemo-IO Study

This phase III ALCHEMIST trial compares the addition of pembrolizumab to usual chemotherapy versus usual chemotherapy for the treatment of stage IB, II, or IIIA non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the …

carcinoma
platelet count
paclitaxel
pembrolizumab
neutrophil count
Northwest Hospital Center
 (3.9 away) Contact site
  • 136 views
  • 25 Nov, 2020
  • +675 other locations
A Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine

The reason for this study is to see if lasmiditan is safe and effective in children aged 6 to 17 with migraine. The study will last up to 20 weeks and may include up to 4 visits.

preventive medication
lasmiditan
headache
ly573144
PharmaSite Research Inc
 (4.0 away) Contact site
  • 122 views
  • 25 Nov, 2020
  • +211 other locations
Study to Continue Treatment With Darolutamide in Patients Who Have Been Participating in Previous Darolutamide Studies Supported by Bayer

The aim of this study is to provide darolutamide treatment to patients who participated in a previous study with darolutamide supported by Bayer and the treating doctor considers that the continuation of the treatment with darolutamide to be beneficial. Patients will be carried over from the previous studies and continue …

Chesapeake Urology Associates
 (9.3 away) Contact site
  • 0 views
  • 23 Nov, 2020
  • +224 other locations
Open-Label Extension of RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis

The purpose of this study is to determine the long-term safety of RPC1063 for the treatment of all patients with moderate to severe Ulcerative Colitis (UC) as well as the long-term efficacy of RPC1063 for the treatment of adult patients with moderate to severe UC. Additionally, to determine the long-term …

mercaptopurine
prednisone
aminosalicylates
methotrexate
budesonide
Woodholme Gastroenterology
 (6.7 away) Contact site
  • 0 views
  • 07 Oct, 2020
  • +293 other locations
A Study to Evaluate the Safety and Efficacy of Relugolix in Men With Advanced Prostate Cancer

The purpose of this study is to determine the efficacy and safety of relugolix 120 milligrams (mg) orally once daily for 48 weeks on maintaining serum testosterone suppression to castrate levels (< 50 nanograms/deciliter [ng/dL]) in participants with androgen-sensitive advanced prostate cancer.

androgens
metastasis
prostatectomy
serum testosterone
testosterone
Baltimore
 (7.6 away) Contact site
  • 1590 views
  • 04 Nov, 2020
  • +351 other locations
S0820 Adenoma and Second Primary Prevention Trial

The investigators hypothesize that the combination of eflornithine and sulindac will be effective in reducing a three-year event rate of adenomas and second primary colorectal cancers in patients previously treated for Stages 0 through III colon or rectal cancer.

rectal carcinoma
unstable angina
aspirin
adenoma
anticoagulants
Kaiser Permanente-Woodlawn Medical Center
 (6.5 away) Contact site
  • 2518 views
  • 24 Nov, 2020
  • +1023 other locations
Phase 3 Study of ProstAtak Immunotherapy With Standard Radiation Therapy for Localized Prostate Cancer

The purpose of this study is to evaluate the effectiveness of ProstAtak immunotherapy in combination with radiation therapy for patients with intermediate-high risk localized prostate cancer. ProstAtak kills tumor cells and stimulates a cancer vaccine effect. Killing tumor cells in an immune stimulatory environment induces the body's immune system to …

androgens
external beam radiation therapy
antiandrogen therapy
cancer vaccine
androgen suppression
Chesapeake Urology Research Associates
 (9.3 away) Contact site
  • 1420 views
  • 05 Nov, 2020
  • +76 other locations